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Abstract
Introduction:  Squamous  cell  carcinoma  is  the  most  common  neoplasm  of  the  larynx  and  glottis,
and its  prognosis  depends  on  the  size  of  the  lesion,  level  of  local  invasion,  cervical  lymphatic
spread, and  presence  of  distant  metastases.  Ki-67  (MKI67)  is  a  protein  present  in  the  core,
whose function  is  related  to  cell  proliferation.
Aim:  To  evaluate  the  expression  of  marker  Ki-67  in  squamous  cell  carcinoma  of  the  larynx  and
glottis and  its  correlation  to  pathological  ﬁndings.
Methods:  Experimental  study  with  immunohistochemistry  analysis  of  Ki-67,  calculating  the  per-
centage of  the  cell  proliferation  index  in  glottic  squamous  cell  carcinomas.
Results: Sixteen  cases  were  analyzed,  with  six  well-differentiated  and  10  poorly/moderately
differentiated  tumors.  There  was  a  correlation  between  cell  proliferation  index  and  degree  of
cell differentiation,  with  higher  proliferation  in  poorly/moderately  differentiated  tumors.
Conclusion:  The  cell  proliferation  index,  as  measured  by  Ki-67,  may  be  useful  in  the  character-
ization of  histological  degree  in  glottic  squamous  cell  tumors.
© 2014  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Published  by
Elsevier Editora  Ltda.  All  rights  reserved.
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PALAVRAS-CHAVE
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e  pescoc¸o
Correlac¸ão  histológica  da  expressão  do  Ki-67  no  Carcinoma  Epidermoide  Glótico  de
acordo  com  grau  de  diferenciac¸ão celular
Resumo
Introduc¸ão:  O  carcinoma  de  células  escamosas  é  a  neoplasia  mais  frequente  da  laringe  e
da região  glótica,  seu  prognóstico  depende  do  tamanho  da  lesão,  do  nível  de  invasão  local,
disseminac¸ão cervical  linfática  e  da  existência  de  metástases  à  distância.  Ki-67  (MKI67)  é  uma
proteína presente  no  núcleo,  cuja  func¸ão  está  relacionada  com  a  proliferac¸ão  celular.
Objetivos:  Avaliar  a  expressão  do  marcador  Ki-67  em  carcinoma  de  células  escamosas  da  laringe
glóticos e  correlacionar  sua  expressão  com  os  achados  anatomopatológicos.
Método:  Trabalho  experimental  de  análise  imunohistoquímica  do  Ki  67  através  do  cálculo  per-
centual do  índice  de  proliferac¸ão  celular  em  produtos  de  carcinomas  epidermóides  glóticos.
Resultados:  Dezesseis  casos  foram  analisados,  sendo  seis  bem  diferenciados  e  dez
pouco/moderadamente  diferenciados.  Houve  correlac¸ão  entre  o  índice  de  proliferac¸ão  celu-
lar e  o  grau  de  diferenciac¸ão  celular,  sendo  a  proliferac¸ão  maior  nos  pouco/moderadamente
diferenciados.
Conclusão:  O  índice  de  proliferac¸ão  celular,  medido  pelo  Ki-67  pode  ser  útil  na  caracterizac¸ão
do grau  histológico  em  tumores  glóticos  de  células  escamosas.
© 2014  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Publicado  por
Elsevier Editora  Ltda.  Todos  os  direitos  reservados.
Table  1  Broders’  classiﬁcation.
Broders’  histological  classiﬁcation
Parameter  Characteristics
Grade  I  0--25%  undifferentiated  cells
Grade  II  25--50%  undifferentiated  cells
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in  situ. When  it  only  affects  the  lamina  propria,  it  is  consid-Introduction
Squamous  cell  carcinoma  is  the  most  common  neoplasm  of
the  larynx  and  glottic  region,  and  its  prognosis  depends  on
the  size  of  the  lesion,  level  of  local  invasion,  lymphatic
spread,  and  presence  of  distant  cervical  metastases.1--5 The
behavior  of  the  squamous  cell  carcinoma  is  marked  by  the
degree  of  cell  proliferation  and  differentiation,  and  this
index  can  be  derived  by  measuring  Ki-67.6--10
Histologically,  the  epidermoid  or  squamous  cell  carci-
noma  in  these  regions  is  similar  to  the  others.  It  is  deﬁned
by  the  neoplastic  proliferation  of  squamous  cells  in  differ-
ent  degrees  of  differentiation  and  their  inﬁltrative  nature.
Depending  on  the  power  of  keratinization  and  cellular
atypia,  they  are  classiﬁed  as  follows:  well,  moderately,  or
poorly  differentiated.1
The  well-differentiated  type  is  characterized  by  its  sim-
ilarity  with  normal  squamous  epithelium,  high  power  of
keratinization,  and  very  mild  cell  atypia;  the  moderately  dif-
ferentiated  type  contains  distinct  nuclear  pleomorphism  and
mitotic  activity  is  present,  including  atypical  ﬁgures.  In  this
type,  keratinization  is  much  lower.1,2 In  the  poorly  differen-
tiated  type,  there  is  a  predominance  of  immature  cells,  with
numerous  mitotic  ﬁgures  and  virtually  absent  keratinization.
The  level  of  invasion  may  be  limited  to  the  epithelium,
respecting  the  basal  lamina,  which  is  called  in  situ. When  it
affects  only  the  lamina  propria,  it  is  considered  microinva-
sive  or  superﬁcially  invasive.2
As  for  the  frankly  invasive  carcinoma,  it  manifests  as  the
destruction  of  the  basal  lamina,  clearly  extending  to  the
underlying  tissues,  possibly  accompanied  by  stromal  reac-
tion.  Perineural  invasion  and  angiolymphatic  invasion  are
signs  of  increased  aggressiveness  and  change  in  staging,
respectively.3Broders  proposed  a  grading  system  for  squamous  cell
carcinomas.11,12 The  classiﬁcation  established  in  1920
and  subsequently  reviewed  in  1925  was  based  on  the
e
dGrade III  50--75%  undifferentiated  cells
Grade IV  75--100%  undifferentiated  cells
undamental  principle  of  cellular  differentiation,  and  was
ompletely  dissociated  from  clinical  history.  Carcinomas
ere  divided  into  four  grades,  ranging  from  I to  IV.  Car-
inomas  of  grade  I had  up  to  25%  undifferentiated  cells.
rade  II  tumors  had  25--50%  undifferentiated  cells.  Grade  III
umors  consisted  of  50--75%  undifferentiated  cells  and  Grade
V  tumors  had  75--100%  undifferentiated  cells  (Table  1).11,12
The  histopathological  classiﬁcation  of  malignancy  pro-
osed  by  the  World  Health  Organization  (WHO,  2005)  was
ased  on  the  degree  of  cell  differentiation  and  allowed  the
lassiﬁcation  of  this  malignancy  into  three  categories,  as
ell-,  moderately  and  poorly  differentiated  (Table  2).2,11--13
The  well-differentiated  tumor  is  characterized  by  sim-
larity  with  normal  squamous  epithelium,  high  power  of
eratinization,  and  very  mild  cell  atypia;  the  moderately
ifferentiated  contains  distinct  nuclear  pleomorphism,  pres-
nce  of  mitotic  activity,  including  atypical  ﬁgures.  In  this
ype,  keratinization  is  much  lower.2 In  the  poorly  differ-
ntiated  type,  immature  cells  predominate  with  numerous
itotic  ﬁgures  and  keratinization  is  virtually  absent.
egarding  the  power  of  invasion,  it  can  be  limited  to  the
pithelium,  respecting  the  basal  lamina,  when  it  is  calledred  microinvasive  or  superﬁcially  invasive.2
The  frankly  invasive  carcinoma  is  manifested  by  the
estruction  of  the  basal  lamina  with  clear  extension  to
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Table  2  Classiﬁcation  recommended  by  the  World  Health
Organization  (WHO).
Histological  classiﬁcation  --  WHO
Parameter  Characteristics
Poorly  differentiated Predominance  of  immature  cells
Abundant  typical  and  atypical
mitoses
Minimal  keratinization
Moderately
differentiated
Some  degree  of  pleomorphism  and
mitotic  activity
Little  keratinization
Well-differentiated  Tissue  architecture  similar  to  the
normal  pattern  of  squamous
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nderlying  tissues,  possibly  accompanied  by  stromal  reac-
ion.  Perineural  invasion  and  angiolymphatic  invasion  are
igns  of  increased  aggressiveness  and  change  in  staging,
espectively.3
The  measurement  of  mitotic  ﬁgures,  a  common  practice
n  the  evaluation  of  tumors  regarding  their  growth  rate  and
egree  of  aggressiveness,  is  far  from  its  desired  accuracy,
ince  it  is  not  possible  to  know,  through  histological  sections
outinely  stained  with  H&E,  which  are  exactly  the  cells  that
ntered  the  cell  division  cycle.  This  is  due  to  the  fact  that
he  phases  G1,  S,  and  G2  of  the  cell  cycle  are  not  identiﬁed
y  optical  microscopy  (Fig.  1).12
Ki-67  (MKI67)  is  a  protein  present  in  the  nucleus,  whose
unction  is  related  to  cell  proliferation.  This  protein  is
nly  expressed  in  the  cell  division  cycle:  interphase  (G1,  S,
2),  prophase,  metaphase,  anaphase,  and  telophase,  and  is
bsent  in  the  G0  phase,  when  the  cell  is  quiescent;  there-
ore,  it  is  an  excellent  marker  of  cell  division.11--13
The  monoclonal  antibody  Ki-67  is  used  to  demonstrate
he  expression  of  this  nuclear  protein.  This  antibody  binds
o  its  speciﬁc-antigen  (MKi67)  present  in  the  nuclei  of  pro-
iferating  cells,  staining  them  and  highlighting  all  cells  that
ave  entered  the  cell  division  cycle.12,13Through  optical  microscopy  it  is  possible  to  count  the
umber  of  cells  per  ﬁeld  or  ‘‘hot  spot’’  areas,  which  are
tained,  and  to  calculate  the  proliferation  index  (Ki-67
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Figure  1  Phases  of  cell  cycle.  G1,  S,  G  --  presence  of  MKI67.
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ndex).  The  analysis  of  this  index  is  what  allows  for  the
haracterization  of  the  degree  of  tumor  cell  proliferation
growth  rate)  and  consequently,  its  degree  of  aggressive-
ess,  increased  risk  of  new  tumor  clones,  and  mutations,
hich  hinder  tumor  restriction  by  the  immune  system.12,13
This  study  aimed  to  evaluate  the  expression  of  the  Ki-67
arker  in  glottic  squamous  cell  carcinoma  of  the  larynx  and
orrelate  it  regarding  pathological  ﬁndings  and  cell  prolifer-
tion  characteristics.
aterials and methods
his  was  an  experimental  clinical  study  performed  with  a
ross-section  in  a  historical  cohort,  using  resection  speci-
ens  from  glottic  squamous  cell  carcinoma  of  patients  from
 tertiary  care  university  hospital.  The  patients  were  submit-
ed  to  hemi-laryngectomy,  total  laryngectomy,  and  removal
f  the  vocal  cords  with  their  respective  lymphadenectomy.
To  facilitate  the  statistical  analysis  of  glottic  tumors,
hey  were  divided  into  well-differentiated  and  moder-
tely/poorly  differentiated.
Cases  of  glottic  squamous  cell  carcinoma  tumors  were
btained  from  the  database  of  the  Pathological  Anatomy
epartment  of  a  tertiary  university  hospital  in  the  period  of
994--2004.  This  sample  included  99  cases  in  total:  85  cases
ere  moderately/poorly  differentiated  tumors,  of  which  41
ases  were  products  of  surgical  specimens  and  44  cases
ere  biopsies  that  were  not  treated  surgically  (chemother-
py/radiotherapy).  Fourteen  cases  were  well-differentiated
umors,  with  eight  cases  representing  products  of  surgical
pecimens  and  six  biopsy  cases  that  were  not  treated  surgi-
ally  (chemo/radiotherapy).
The  study  only  included  cases  that  had  surgical  speci-
ens,  excluding  biopsy  cases,  as  they  would  bring  bias  to  the
tudy  by  including  random  tumor  fragments.  Of  eight  well-
ifferentiated  products  of  surgical  specimens,  two  cases  did
ot  have  parafﬁn  blocks  available  for  new  sections.
Therefore,  the  study  was  conducted  with  six  cases  of
ell-differentiated  glottic  laryngeal  tumors,  and  10  cases  of
oderately/poorly  differentiated  glottic  laryngeal  tumors
ere  randomly  selected  to  comprise  the  control  group.  The
roups  did  not  have  the  same  number  of  cases,  as  there  were
ot  enough  cases  of  well-differentiated  tumors  to  complete
he  group.
The  inclusion  criteria  were  glottic  laryngeal  tumors  for
hich  parafﬁn  blocks  were  identiﬁed  and  that  contained
nough  material  for  new  sections.  Clinical  data  and  tumor
taging  were  obtained  from  medical  records  (Table  3).
The  study  was  approved  by  the  ethics  committee  of  the
nstitution  (no.  485/11).
Immunohistochemical  analysis  was  performed  with  the
vidin--biotin--peroxidase  method  and  used  the  following
ntibody:  Ki-67  (Clone  MIB-1,  IgG1,  1:150,  Dako  brand,  pre-
reated  Tris--EDTA).
Positive  and  negative  controls  of  the  marker  were  used,
n  order  to  compare  them  with  the  studied  cases.  Lymphoid
issue  was  used  as  positive  control.The  specimens  were  analyzed  randomly,  by  an  investiga-
or  who  had  no  knowledge  of  the  previous  diagnosis  given  by
he  pathologist  and  no  knowledge  of  the  patient’s  clinical
tatus,  comparing  them  with  the  positive  and  negative
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Table  3  Clinical  data  of  study  patients.
Clinical  data  Group  1  Group  2  Obs
TNM  T1N0M0  --  four  cases  T1N0M0  --  three  cases
T2NOMO  --  one  case  T2N0M0  --  ﬁve  cases
T3N0M0  --  one  case  T2N1M0  --  one  case
T3N0M0  --  one  case
Alcohol consumption  50%  (3  cases)
Smoking  67%  (4  cases)
Gender  4  M:2  F  10  M:0  F
Age 53  (37--73)  58  (39--70)
Preop. clinical  neck Negative  1  positive  case  (N1)
Margins 50%  positive 100%  negative
Vascular  invasion 100%  negative 80%  negative 2  cases+
Neural involvement  100%  negative  90%  negative  1  case+
Extracapsular  extension  100%  negative  100%  negative
Preop. radiotherapy  0  cases  1  case
Postop. radiotherapy  50%  (3  cases)  20%  (2  cases)
Preop. chemotherapy  0  cases  0  cases
Postop. chemotherapy  0  cases  0  cases
Total 6  patients  10  patients
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controls.  Pictures  scanned  at  high  magniﬁcation  (400×)
were  taken  from  highly  reactive  areas  (hot  spots),  using  a
Nikon  camera  (Coolpix  995).  Subsequently,  the  images  were
uploaded  to  the  computer  for  histological  analysis,  using
the  software  Imagelab  2000.  All  parameters  were  blindly
evaluated.
The  evaluation  of  the  cell  proliferation  rate  was  per-
formed  using  common  percentage  ratio,  as  it  already  has
been  used  in  literature.8,9 Five  areas  of  greater  intensity
of  immunomarker  expression  (hot  spots)  were  selected.  At
least  500  cells  were  counted,  and  the  ratio  between  the
number  of  cells  that  had  a  positively  stained  nucleus  and  the
total  number  of  cells  was  calculated.  The  percentage  ratio
was  stratiﬁed  as  follows:  <5%  --  low  cell  proliferation  rate;
between  5%  and  10%  --  mild  cell  proliferation  rate;  between
10%  and  30%  --  moderate  cell  proliferation  rate;  and  >30%  --
high  cell  proliferation  rate.
To  simplify  and  better  analyze  the  data,  they  were
grouped  as  follows:
Cell  proliferation  index:--  Low/mild  cell  proliferation.
--  Moderate/high  cell  proliferation.
Histological  type:
v
d
t
Table  4  Distribution  of  cases  according  to  histological  type  and  c
Well-differentiated  
Ki-67  Low/mild  4  
Moderate/high  2  
Total 6  oorly differentiated glottic SCC; Preop., preoperative; Postop.,
- Glottic,  well-differentiated.
- Glottic,  moderately/poorly  differentiated.
tatistical  analysis
fter  pooling  of  the  data,  the  statistical  analysis  was  carried
ut  with  IBM  SPSS  Statistics® software,  using  the  Chi-squared
est  and  Fisher’s  exact  test.
esults
 total  of  16  cases  were  evaluated,  with  six  well-
ifferentiated  and  10  moderately/poorly  differentiated
ases.
Among  the  well-differentiated  glottic  tumors  (n  =  6
ases),  four  cases  had  low/mild  cell  proliferation  and  two
ases  had  moderate/high  cell  proliferation.  Among  the  mod-
rately/poorly  differentiated  glottic  tumors  (n  =  10  cases),
ne  case  had  low/mild  cell  proliferation  and  nine  cases  had
oderate/high  cell  proliferation.
In  the  correlation  analysis  of  cell  differentiation  degree
ersus  cell  proliferation  index,  statistical  signiﬁcance  was
emonstrated  (p  <  0.05)  when  comparing  the  groups  through
wo-tailed  Fisher’s  exact  test,  with  p  =  0.036.
ell  proliferation.
Histological  type  Total
Moderately/poorly  differentiated
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Considering  the  histological  type  as  the  gold  standard  to
ssess  cell  differentiation  in  laryngeal  carcinomas,  the  cell
roliferation  index  had  a  sensitivity  of  0.9,  speciﬁcity  of
.67,  positive  predictive  value  of  0.82,  and  negative  pre-
ictive  value  of  0.8  (Table  4).
iscussion
he  cell  proliferation  index  was  positively  correlated  with
he  degree  of  cell  differentiation,  and  was  higher  in  moder-
tely/poorly  differentiated  cases.  This  ﬁnding  corroborates
he  idea  that  the  more  undifferentiated  the  neoplasm,  the
oorer  the  control  of  the  cell  division  process  and  the
reater  the  proliferation.8 This  evaluation  showed  statis-
ical  signiﬁcance  between  tumor  type  correlation  and  cell
roliferation  index  (p  <  0.05).
The  studies  by  Rodrigues  et  al.  found  no  correlation
etween  the  immunohistochemical  expression  of  Ki-67  and
rognostic  value;7,14,15 however,  it  appears  that  Ki-67  over-
xpression  associated  with  the  idea  of  mitotic  disarray,
ncontrolled  cell  growth,  and  proliferation  would  be  associ-
ted  with  prognostic  factors  and  approach  prioritization  of
hese  patients.
An  interesting  fact  was  pointed  out  in  a  Canadian
etrospective  study  on  the  clinical  use  of  Ki-67,  which
emonstrated  that  its  overexpression  is  correlated  with  high
isk  of  cervical  recurrence  after  radiotherapy  and,  there-
ore,  such  cases  should  undergo  more  targeted  treatment
t  earlier  stages.16
Other  head  and  neck  tumor  sites,  such  as  the  oral  cav-
ty,  also  provide  evidence  that  over  expression  of  markers
uch  as  p53  and  Ki-67  constitute  a  greater  risk  and  poorer
rognosis  for  this  type  of  squamous  cell  carcinoma.17
In  a  study  with  animals  exposed  to  tobacco,  only  the
evelopment  of  benign  lesions  was  observed,  with  no  pro-
ression  to  malignant  tumors.  Histological  evaluation  of
hese  animals  showed  absence  of  p53  marking,  but  Ki-67
ositivity  associated  with  the  tobacco-induced  lesion  was
bserved.18
When  assessing  the  clinical  prognosis  of  patients  with  epi-
ermoid  carcinomas  of  the  larynx,  it  was  observed  that  the
i-67  marker  associated  with  Ki-S11  is  an  important  tool  to
id  in  clinical  management  and  prognostic  analysis.  Patients
ith  low  cell  proliferation  rate  assessed  by  these  markers
ave  a  lower  recurrence  rate  with  statistical  signiﬁcance
p  < 0.05)  and  improved  ﬁve-year  survival  when  compared
o  the  group  with  high  cell  proliferation  rate.19
Regarding  the  clinical  application  of  Ki-67,  it  was  also
hown  that  the  group  of  patients  with  expression  considered
o  be  positive  had  higher  rate  of  local  recurrence,  even  after
adiotherapy.  It  is  suggested  that  these  patients  have  a  per-
onalized  and  more  detailed  follow-up  protocol.16 However,
n  another  group,  it  was  identiﬁed  that  patients  with  glottic
umors  involving  the  anterior  commissure  and  showing  over
xpression  of  Ki-67  had  a  better  outcome  and  had  tumors
onsidered  to  be  radio-sensitive,  with  signiﬁcant  relevance
f  results.20The  literature  also  indicates  the  methodology  used  in
he  anatomopathological  evaluation  of  advanced  epider-
oid  carcinoma  of  the  larynx.  In  the  aforementioned  study,
he  heterogeneity  in  Ki-67  expression  was  demonstrated  in
F
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reas  of  tumor  cell  activity  and,  therefore,  an  assessment
ethodology  should  be  well-established,  and  the  variabil-
ty  of  previous  studies  that  correlated  the  expression  of
mmunomarkers  with  prognostic  factors  can  be  explained
y  such  characteristic.21
The  evaluation  of  carcinoma  precursor  lesions  (hyperpla-
ia,  carcinoma  in  situ) was  also  performed  in  studies  with
mmunomarkers  such  as  Ki-67  and  p-16.  Of  these  lesions,  car-
inoma  in  situ  tends  to  have  a  higher  positivity  than  isolated
yperplasias.22
Although  the  present  study  found  a  signiﬁcant  corre-
ation  between  cell  proliferation  degree  and  histological
umor  differentiation,  there  were  two  cases  (18%)  in  which
he  rate  of  cell  proliferation  was  moderate/high  even  in
ell-differentiated  tumors.  Considering  that  even  some
ell-differentiated  tumors  showed  high  cell  proliferation
ndex,  these  tumors  possibly  exhibit  a  more  aggressive
ehavior,  as  with  the  increased  population  of  tumor  cells,
he  chance  of  mitotic  disarray  is  greater.
New  clones  that  may  be  more  aggressive  due  to  mutations
nd  that  hinder  restriction  by  the  immune  system  may  have
etter  response  to  chemotherapy  and  radiotherapy.  Future
tudies  that  assess  the  behavior  of  well-differentiated
umors  with  high  rate  of  cell  proliferation  may  assist  in  the
anagement  of  these  patients.
It  is  noteworthy  that  although  this  study  had  a  sam-
le  of  16  patients,  limited  by  the  difﬁculty  in  obtaining
urgical  material  from  well-differentiated  glottic  cases,  it
mphasized  the  analysis  of  this  speciﬁc  region  of  the  lar-
nx,  different  from  other  studies  with  larger  samples  that
ncluded  patients  with  carcinomas  in  any  region  of  the
arynx.  Therefore,  the  present  study  corroborates  the  cor-
elation  between  increased  expression  of  Ki-67  in  more
ndifferentiated  tumors,8 and  demonstrates  that  this  cor-
elation  also  applies  speciﬁcally  to  laryngeal  glottic  tumors.
The  authors  believe  that  the  association  between  the
xpression  of  Ki-67  with  clinical  criteria  and  prognosis
emains  unclear.  This  association  is  still  quite  controversial
n  the  medical  literature,  in  both  clinical  and  experimen-
al  studies.  The  relevance  of  using  immunomarkers  is  clear;
owever,  further  studies  are  necessary  to  better  deﬁne  the
atients  in  which  immunomarkers  should  be  used  in  clinical
ractice.
onclusion
his  study  demonstrated  that  the  rate  of  cell  proliferation
easured  by  Ki-67  may  be  useful  in  characterizing  the  histo-
ogical  grade  in  glottic  squamous  cell  tumors  of  the  larynx.
urther  studies  are  needed  to  evaluate  the  behavior  of  well-
ifferentiated  tumors  with  high  rate  of  cell  proliferation
o  deﬁne  the  best  therapeutic  approach  in  these  patients.
ther  factors  must  be  involved  regarding  the  pathogenesis
nd  tumor  progression  of  this  disease  in  the  glottis.unding
his  study  was  supported  by  PIBIC/CNPq.
ll  car
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